Overview

The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if small oral and sublingual doses of milk protein are safe and effective in decreasing sensitivity to cow's milk in allergic children.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Robert A. Wood
Collaborators:
Duke University
Greer Laboratories
Treatments:
Caseins
Immunologic Factors